Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers.

导出 OA

翻译打印收藏纠错

作者： Kazuo,Okadome ^[1] ; Yoshifumi,Baba ^[1] ; Daichi,Nomoto ^[2] ; Taisuke,Yagi ^[1] ; Rebecca,Kalikawe ^[1] ; Kazuto,Harada ^[1] ; Yukiharu,Hiyoshi ^[1] ; Yohei,Nagai ^[1] ; Takatsugu,Ishimoto ^[1] ; Masaaki,Iwatsuki ^[1] ; Shiro,Iwagami ^[1] ; Yuji,Miyamoto ^[1] ; Naoya,Yoshida ^[1] ; Masayuki,Watanabe ^[1] ; Yoshihiro,Komohara ^[3] ; Takashi,Shono ^[4] ; Yutaka,Sasaki ^[5] ; Hideo,Baba ^[5]

作者单位： Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. ^[1] Department of Next-Generation Surgical Therapy Development, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. ^[2] Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. ^[3] Department of Cell Pathology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. ^[4] Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. ^[5] Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. hdobaba@kumamoto-u.ac.jp. ^[6]